Sep 22, 2020 / NTS GMT
Unidentified Participant
Thanks you so much for joining this session. Again, I'm [Chai Hong], I'm one of the Board of Directors for TMA, and I will introduce the speakers, who will play out a video and then we'll open up to live Q&A at the end.
So it is my pleasure to introduce our next presenters, Dr. Noreen Roth Henig, Chief Medical Officer; and Dr. Mary Katherine (MK) Farmer, Senior Medical Director of Kezar Life Sciences, Inc. Kezar Life Sciences is a South San Francisco-based biotechnology company that combines courage, conviction, and cutting-edge science to develop breakthrough treatments for immune mediated and oncologic disorders, helping patients to overcome their disease and live a better life.
Dr. Henig is an accomplished leader whose career spans clinical practice, academic medicine, translational science, clinical development, medical and regulatory affairs. She is a Board-certified physician in pulmonary critical care and Board eligible in allergy and immunology. Dr. Henig received her BA from Yale University (
Kezar Life Sciences Inc At TMA's International Annual Patient Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot